Obesity-associated hypogonadism is a hormonal condition seen in some men with excess body fat. 

It is characterised by low total and free testosterone levels, with luteinising hormone (LH) that is low or inappropriately normal rather than elevated. 

This pattern indicates a functional, central problem involving reduced signalling from the hypothalamus and pituitary, rather than primary testicular failure. 

Excess fat tissue contributes through hormonal conversion, inflammatory signalling, and metabolic disruption, leading to lower testosterone, impaired fertility, and adverse effects on body composition and energy levels.

Fat As An Endocrine Organ

Body fat is not simply an energy store; it functions as an endocrine organ. 

Adipose tissue releases hormones and inflammatory signals that communicate with the brain and other organs. 

The discovery of leptin highlighted fat’s role in signalling energy status to the brain. 

Fat tissue also produces adipokines and inflammatory cytokines that influence metabolism, insulin sensitivity, and hormone balance. 

In addition, adipose tissue converts testosterone to oestrogen via aromatase, disrupting normal brain–testis signalling and contributing to low testosterone and reduced fertility.

Aromatase Activity and Testosterone Decline

In men with excess body fat, increased aromatase activity converts more testosterone into oestrogen. 

As fat mass rises, testosterone levels fall, and oestrogen levels increase. 

Raised oestrogen suppresses LH release from the brain, reducing testicular testosterone production. 

This results in low testosterone with low or normal LH, the typical hormonal pattern seen in obesity-related hypogonadism. 

Visceral fat appears particularly harmful in driving this imbalance.

Insulin Resistance and Inflammation

Obesity-related insulin resistance and chronic inflammation further suppress testosterone. 

High insulin levels reduce liver production of sex hormone-binding globulin (SHBG), lowering total testosterone. 

At the same time, inflammatory signals released by excess fat directly impair testicular testosterone production. 

These processes interact, reinforcing hormonal disruption and metabolic dysfunction.

The Vicious Cycle

Obesity and low testosterone reinforce each other. 

Excess fat lowers testosterone through hormonal conversion, insulin resistance, and inflammation. 

Falling testosterone then promotes loss of muscle mass and accumulation of visceral fat, further worsening insulin resistance and inflammation. 

This self-perpetuating cycle explains why untreated hypogonadism can make weight management increasingly difficult.

Impact on Fertility

Obesity affects male fertility through both hormonal and testicular mechanisms. 

Lower testosterone and higher oestrogen reduce the hormonal signals required for sperm production. 

Inflammation and oxidative stress within the testes further impair sperm development and quality, contributing to reduced fertility.

Other Hormonal Players

Obesity disrupts the wider reproductive hormone system. 

High insulin levels lower SHBG, altering androgen availability. 

Hormones released from fat tissue, such as leptin, interfere with hypothalamic signalling, while increased oestrogen suppresses LH and follicle-stimulating hormone (FSH) release. 

Reduced inhibin B reflects impaired sperm production. 

Together, these changes weaken effective androgen action and reproductive function.

Clinical Signs and Symptoms

Obesity-related hypogonadism causes a combination of sexual, physical, and psychological symptoms. 

Common features include…..

• Reduced libido
• Erectile dysfunction
• Fatigue
• Low mood
• Reduced physical performance
• Loss of muscle mass
• Increased central fat.
   

These symptoms are not specific and often overlap with other obesity-related conditions, making biochemical testing essential for diagnosis.

Diagnosis and Tests

Diagnosis relies on blood tests rather than symptoms alone. 

Testosterone should be measured early in the morning on at least two separate occasions. 

If results are borderline, SHBG should be assessed to calculate free testosterone. LH and FSH levels then help identify whether the cause is testicular or central. 

This stepwise approach reduces misdiagnosis and inappropriate treatment.

What Happens If Left Untreated?

Untreated obesity-related hypogonadism can lead to progressive worsening of…

• Sexual dysfunction
• Muscle loss
• Increased fat mass
• Reduced bone density
• Higher metabolic 
• Cardiovascular risk.
  
  

Low testosterone may both reflect and contribute to poor long-term health outcomes.

Management and Treatment

Management focuses on addressing the underlying metabolic cause. 

Weight loss through dietary change, regular physical activity, and, where appropriate, bariatric or metabolic surgery can restore testosterone levels in many men. 

Testosterone replacement therapy may be considered only when low testosterone and symptoms persist despite weight loss and are confirmed by repeated testing. 

Treatment aims to improve symptoms, body composition, and long-term health, with careful monitoring for potential side effects. 

TRT requires careful, ongoing monitoring for side effects, including raised red blood cell levels, prostate health issues, and possible cardiovascular effects, making individualised treatment and shared decision-making essential.

Summary

Obesity-related male hypogonadism results from hormonal disruption driven by excess fat tissue, including increased oestrogen production, insulin resistance, and chronic inflammation. 

These changes lower testosterone, impair fertility, and worsen metabolic health. 

Weight reduction remains the cornerstone of treatment and often leads to hormonal recovery. 

When low testosterone persists despite lifestyle intervention, medical treatment may be appropriate.

Addressing both metabolic and hormonal imbalances is essential for long-term health.